✦ LIBER ✦

Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions

✍ Scribed by Bohua Li; Hao Wang; Jianxin Dai; Junjie Ji; Weizhu Qian; Dapeng Zhang; Sheng Hou; Yajun Guo

Book ID: 108781768
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 375 KB
Volume: 0
Category: Article
ISSN: 0019-2805
DOI: 10.1111/j.1365-2567.2005.02247.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bispecific F(ab′)2 monomer prepared with

Bispecific F(ab′)2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells

✍ Taizo Nitta; Hideo Yagita; Takachika Azuma; Kiyoshi Sato; Ko Okumura 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

## Bispecific F(ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells Induction of cytolytic activity of peripheral blood mononuclear cells towards target cells was studied by preparing bispecific F(ab')2 which was compo

Immunotoxins constructed with anti-CD25

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin a-chain have potent anti-tumour effects against human hodgkin cells in vitro and solid hodgkin tumours in mice

✍ Andreas Engert; Gary Martin; Peter Amlot; John Wijdenes; Volker Diehl; Philip Th 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 867 KB

## Abstract Twenty‐three monoclonal antibodies (MAbs) against the IL‐2 receptor α‐chain (CD25) were evaluated as ricin A‐chain immunotoxins for the treatment of Hodgkin's disease. Primary screening used an indirect assay in which the cells were treated with the test antibody followed by a Fab immun

Generation of a monoclonal anti-GP70 ant

Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients

✍ Yair Gazitt; Marei Sammar; Abraham J. Treves; Noga Manny; Dorit Gurfel; Aaron Po 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Phase I, double-blind, randomized, place

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease

✍ C. Janneke van der Woude; Pieter Stokkers; Ad A. van Bodegraven; Gert Van Assche 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

Background: NI-0401 is a fully human monoclonal antibody, which binds to the CD3 subunit of the T-cell receptor, causing modulation of T-cell activity. We investigated the safety and the ability to modulate the TCR-CD3 complex of NI-0401 in patients with active Crohn's disease (CD). Methods: A doub